The value of bronchoalveolar lavage and bronchial washings in the diagnosis of invasive pulmonary aspergillosis
References (19)
- et al.
Invasive aspergillosis
Am J Med
(1981) - et al.
Role of fiberoptic bronchoscopy in the diagnosis of invasive pulmonary aspergillosis in patients with acute leukemia
- et al.
Bronchoalveolar lavage in the diagnosis of pulmonary infiltrates in patients with acute leukemia
Chest
(1988) - et al.
Significance of isolation of Aspergillus from the respiratory tract in diagnosis of invasive pulmonary aspergillosis
Am J Med
(1986) - et al.
Diagnostic specificity of a sand which ELISA for Aspergillus related disease
J Allergy Clin Immunol
(1987) - et al.
Aspergillus antigen detection in bronchoalveolar lavage fluid from patients with invasive aspergillosis and aspergillomas
AmJ Med
(1982) - et al.
Treatment of invasive aspergillosis: relation of early diagnosis and treatment to response
Ann Intern Med
(1977) Anoverview of pulmonary fungal infections
Clin Chest Med
(1987)- et al.
The role of broncho-alveolar lavage in the diagnosis of invasive pulmonary aspergillosis
Am J Clin Pathol
(1986)
Cited by (144)
Evaluation of MucorGenius® mucorales PCR assay for the diagnosis of pulmonary mucormycosis
2020, Journal of InfectionChronic Pulmonary Aspergillosis in a Patient with Splenectomy
2018, American Journal of MedicineImproving the diagnosis of invasive aspergillosis by the detection of Aspergillus in broncho-alveolar lavage fluid: Comparison of non-culture-based assays
2018, Journal of InfectionCitation Excerpt :However, IA definite diagnosis is still challenging, as clinical and radiological manifestations are most often unspecific. The European Organization for Research and Treatment of Cancer/Mycoses Study Group (EORTC/MSG) recommended using microbiological criteria,3,4 such as the histological evidence of tissue infiltration, although rarely obtained, and mycological culture, although positive in only 50% of patients.5,6 This shortcoming has fuelled an interest in non-culture-based diagnostic techniques applied directly in clinical samples, particularly for non-hematological patients, such as antigen detection (galactomannan (GM), beta-1,3-D glucan) by enzyme-linked immuno-sorbent assay (ELISA), or PCR-based assays targeting the identification of Aspergillus spp. or of genes coding for triazole resistance.
Identification of eukaryotic UDP-galactopyranose mutase inhibitors using the ThermoFAD assay
2017, Biochemical and Biophysical Research CommunicationsA retrospective study of the epidemiology and clinical manifestation of invasive aspergillosis in a major tertiary care hospital in Bahrain
2017, Journal of Infection and Public HealthCurrent and future therapies for invasive aspergillosis
2015, Pulmonary Pharmacology and Therapeutics